News & insights

News

Defining bad faith: Insights from Supreme Court’s ruling in SkyKick v Sky

The Supreme Court has handed down its highly anticipated judgment in the eight-year long litigation between Sky Ltd and SkyKick UK Ltd, centred around what constitutes a bad faith trade mark filing.

Our favourite articles of 2024

Parameters at the EPO: Tips and common pitfalls

Many inventions, particularly in the chemical field, are defined by ‘parameters’ rather than structural features. Parameters are measurable physical or chemical properties used to define an invention ...

Our favourite articles of 2024

Fashion fortified: top tips to combat counterfeiting

Celebrating its 40th year, London Fashion Week is upon us and as the hype of people’s fashions on and off the catwalk grips our attention, now is a good time for brand owners and designers to reflect ...

Food and Drink

The proof is in the packaging: registered design rights in the Food & Drink sector

From eye-catching packaging to innovative product shapes, designs play a crucial role in shaping brand identity. Registered design protection is often overlooked, but it can be a powerful tool for com...

Food and Drink

Sometimes life is a bowl of (real) cherries…and sometimes it’s just the (counterfeit) pits….

Counterfeiting is big business. While estimates vary, the total value of counterfeit goods sold each year is estimated to be at least $1.7 trillion to $4.5 trillion, according to a study by the Libra...

EPO patentability and clinical trials series

Introducing our EPO patentability and clinical trials series

Welcome to our series of articles on the topic of EPO patentability in the context of clinical trials.

Case law

EPO decides that more ‘substances or compositions’ can be claimed in medical use claims

Earlier this year, the European Patent Office (EPO) issued decision T 1252/20, which marks a significant departure from the existing European case law surrounding the patentability of known products f...

News

EPO Enlarged Board to extinguish uncertainty on patent claim interpretation

In oral proceedings held today, on 10 April 2024, the EPO Technical Board of Appeal confirmed it will ask the Enlarged Board of Appeal whether content in the description should be used to interpret th...

News

Moderna’s “off-the-shelf” solid tumour cancer mRNA vaccine trial now underway in the UK

In early February, the first UK patient in Moderna’s Phase 1/2 MOBILIZE trial was administered a new cancer mRNA vaccine, mRNA-4359.

Let us keep you up to date. If you’d like to receive communications from us, ranging from breaking news to technical updates, thought leadership to event invitations, please let us know.

Connect with us